Found: 25
Select item for more details and to access through your institution.
Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment.
- Published in:
- Hematology Reports, 2023, v. 15, n. 4, p. 578, doi. 10.3390/hematolrep15040060
- By:
- Publication type:
- Article
Changes in Hematologic Lab Measures Observed in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors, Ravulizumab and Eculizumab: Real-World Evidence from a US Based EMR Network.
- Published in:
- Hematology Reports, 2023, v. 15, n. 2, p. 266, doi. 10.3390/hematolrep15020027
- By:
- Publication type:
- Article
Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH.
- Published in:
- Health & Quality of Life Outcomes, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12955-023-02195-x
- By:
- Publication type:
- Article
Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.
- Published in:
- Annals of the New York Academy of Sciences, 2014, v. 1329, n. 1, p. 45, doi. 10.1111/nyas.12508
- By:
- Publication type:
- Article
Correction: The Humanistic and Economic Burden of Restless Legs Syndrome.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145139
- By:
- Publication type:
- Article
The Humanistic and Economic Burden of Restless Legs Syndrome.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140632
- By:
- Publication type:
- Article
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 251, doi. 10.1007/s00277-021-04715-5
- By:
- Publication type:
- Article
Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1703, doi. 10.3390/jcm13061703
- By:
- Publication type:
- Article
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health‐related quality of life and productivity.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 4, p. 516, doi. 10.1111/ejh.14139
- By:
- Publication type:
- Article
Fatigue and health‐related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 1, p. 72, doi. 10.1111/ejh.13969
- By:
- Publication type:
- Article
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient‐reported insights on symptoms and quality of life.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 351, doi. 10.1111/ejh.13816
- By:
- Publication type:
- Article
Microfinance - Is There A Solution? A Survey On The Use Of Mfis To Alleviate Poverty In India.
- Published in:
- Denver Journal of International Law & Policy, 2012, v. 40, n. 4, p. 588
- By:
- Publication type:
- Article
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
- Published in:
- JAMA Neurology, 2019, v. 76, n. 7, p. 783, doi. 10.1001/jamaneurol.2019.0447
- By:
- Publication type:
- Article
Association Between Adverse Events and Discontinuation of Antiepileptic Drugs Among Drug-Naïve Adults with Epilepsy.
- Published in:
- Drugs - Real World Outcomes, 2021, v. 8, n. 1, p. 5, doi. 10.1007/s40801-020-00216-5
- By:
- Publication type:
- Article
MDS-124: Patients with Improved Clinical Disease Parameters Also Display Improved Fatigue Following Pegcetacoplan Treatment in Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analyses from the PEGASUS Trial at Week 48.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S339, doi. 10.1016/S2152-2650(21)01792-4
- By:
- Publication type:
- Article
Poster: MDS-124: Patients with Improved Clinical Disease Parameters Also Display Improved Fatigue Following Pegcetacoplan Treatment in Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analyses from the PEGASUS Trial at Week 48.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S228, doi. 10.1016/S2152-2650(21)01436-1
- By:
- Publication type:
- Article
Cardiovascular risk in US adults with nonalcoholic steatohepatitis (NASH) vs. matched non-NASH controls, National Health and Nutrition Examination Survey, 2017–2020.
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0309617
- By:
- Publication type:
- Article
Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 11, p. 4172, doi. 10.1007/s12325-024-02989-5
- By:
- Publication type:
- Article
Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 1, p. 413, doi. 10.1007/s12325-023-02725-5
- By:
- Publication type:
- Article
Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 4, p. 1571, doi. 10.1007/s12325-023-02438-9
- By:
- Publication type:
- Article
The Impact of Once-Monthly Paliperidone Palmitate on Healthcare Utilization Among Patients With Schizophrenia Treated in an Integrated Healthcare System: A Retrospective Mirror-Image Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient and physician perceptions of disease management in Parkinson's disease: results from a US-based multicenter survey.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 1487, doi. 10.2147/NDT.S196930
- By:
- Publication type:
- Article